Related Experiment Video
Updated: Jan 7, 2026

Investigating Migraine-Like Behavior Using Light Aversion in Mice
Published on: August 11, 2021
Food-specific IgG-based elimination diet decreased IL-6, TNF-α, and CGRP and improved symptoms in adults with
Zhiming Zhao1, Meimei Yang2, Fujun Wan1
1Health Center of Screening and Prevention of Diseases, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Background:
Food-specific IgG antibodies have been proposed to be biomarkers to identify food that triggers an inflammation response. We aimed to evaluate the effect of a food-specific IgG-based elimination diet by assessing the changes in the symptoms of migraine and its comorbidities, inflammatory cytokines, neuropeptides, and neurotransmitters, and their correlation.
Methods:
This was a sham-controlled randomized trial. A total of 98 patients with migraine who had at least one positive food-specific IgG antibody were randomly assigned to either the true diet group (IgG-positive foods were excluded, n = 52) or the sham diet group (alternative IgG-negative foods were excluded, n = 46). At baseline and at the end of 12 weeks, seven questionnaires were administered regarding the symptoms of migraine, gastrointestinal symptoms, anxiety, depression, and sleep quality. Fourteen food-specific IgG antibodies, such as IL-6, IL-10, TNF-α, 5-HT, calcitonin gene-related peptide (CGRP), and vasoactive intestinal peptide (VIP), in serum were assessed using enzyme-linked immunosorbent assays.
Results:
At the end of 12 weeks, the true diet group had a larger reduction in questionnaires of migraine (except for MSQ), gastrointestinal symptoms, and poor sleeping, as well as food-specific positive IgG, IL-6, TNF-α, and CGRP in the serum. The difference in the change of "days with migraine in past 4 weeks" between the sham and true diet groups was significantly attenuated after adjusting for IL-6 and TNF-α.
Conclusion:
An IgG-positive food elimination diet improved migraine and its comorbidities and reduced IL-6, TNF-α, and CGRP, which might be associated with the alleviated systemic chronic inflammation and downregulation of the sensitivity of trigeminal nerve endings.
Clinical Trial Registration:
Chictr.org.cn, identifier ChiCTR2000039278.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

